Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.5K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

687
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
687
Learning Disabilities01:25

Learning Disabilities

268
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
268

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fasting Mimicking Diets Reverse Accelerated Biological Aging in Multiple Sclerosis.

Annals of neurology·2025
Same author

Extracellular vesicle miRNA signatures in pediatric onset-multiple sclerosis and obesity-driven immune and metabolic dysregulation.

medRxiv : the preprint server for health sciences·2025
Same author

Circulating extracellular vesicle-miRNAs as epigenetic mediators of metabolic, inflammatory, and neurological pathways in pediatric obesity.

medRxiv : the preprint server for health sciences·2025
Same author

Prevalence of hypertension in pediatric-onset multiple sclerosis and associations with disease course: A case-control study.

Multiple sclerosis and related disorders·2025
Same author

Time to treatment in pediatric patients with repeated episodes of status epilepticus.

BMC neurology·2025
Same author

Menarche and Relapses in Multiple Sclerosis: Associations Between a Physiologic Developmental Milestone and Disease Activity.

Neurology·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Sep 2, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.4K

Pediatric Acquired Demyelinating Disorders.

J Nicholas Brenton

    Continuum (Minneapolis, Minn.)
    |August 8, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric acquired demyelinating disorders require careful diagnosis using clinical and paraclinical factors. Understanding these neuroimmune conditions guides treatment and prognosis in children.

    More Related Videos

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
    04:55

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

    Published on: May 11, 2022

    4.0K
    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    12.4K

    Related Experiment Videos

    Last Updated: Sep 2, 2025

    High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
    10:19

    High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

    Published on: November 23, 2013

    16.4K
    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
    04:55

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

    Published on: May 11, 2022

    4.0K
    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    12.4K

    Area of Science:

    • Neuroimmunology
    • Pediatric Neurology
    • Demyelinating Disorders

    Background:

    • Neuroimmune disorders of the central nervous system are increasingly understood.
    • Distinguishing monophasic from relapsing courses is crucial for management.
    • Pediatric demyelinating disorders have unique characteristics compared to adults.

    Purpose of the Study:

    • To review the clinical presentation, diagnosis, treatment, and prognosis of common acquired demyelinating disorders in children.
    • To highlight factors influencing diagnosis and disease course.
    • To discuss current understanding of immunotherapies in pediatric demyelinating disorders.

    Main Methods:

    • Review of current literature on pediatric acquired demyelinating disorders.
    • Analysis of clinical and paraclinical diagnostic factors.
    • Evaluation of treatment strategies and prognostic indicators.

    Main Results:

    • Clinical presentation, diagnostic evaluation, treatment, and prognosis of monophasic and relapsing acquired demyelinating disorders in children are detailed.
    • Factors such as age, encephalopathy, autoantibodies (MOG, aquaporin-4), oligoclonal bands, and imaging findings aid in diagnosis and predicting disease course.
    • International research has advanced the understanding of immunotherapy safety and efficacy for these conditions in children, including multiple sclerosis.

    Conclusions:

    • Acquired demyelinating disorders in children present distinct phenotypes, treatment considerations, and prognoses.
    • Accurate diagnosis and tailored treatment are essential for optimal outcomes in pediatric patients.
    • Ongoing research continues to refine our understanding and management of these complex neuroimmune disorders.